Icon

JARDIANCE (nda204629)- (10MG,25MG)

EMPAGLIFLOZIN BOEHRINGER INGELHEIM
10MG,25MG
Yes No
2034-Dec-11 2019-Aug-01
None None
None No
JARDIANCE is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated:  to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.  to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.  as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
0 11 0
Total Other Developers 29
Drugs with Suitability Yes
10MG ** ** Up - -
25MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.